Loading…

Development of an 18F-labeled azobenzothiazole tracer for α-synuclein aggregates in the brain

Nuclear imaging of aggregated α-synuclein pathology is an urgent clinical need for Parkinson's disease, yet promising tracers for brain α-synuclein aggregates are still rare. In this work, a class of compact benzothiazole derivatives was synthesized and evaluated for α-synuclein aggregates. Amo...

Full description

Saved in:
Bibliographic Details
Published in:Organic & biomolecular chemistry 2024-06, Vol.22 (22), p.4550-4558
Main Authors: Wu, Jiajun, Mao, Meiting, Yang, Jie, Li, Kexin, Deng, Pengxin, Zhong, Jing, Wu, Xiaoai, Cheng, Yan
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 4558
container_issue 22
container_start_page 4550
container_title Organic & biomolecular chemistry
container_volume 22
creator Wu, Jiajun
Mao, Meiting
Yang, Jie
Li, Kexin
Deng, Pengxin
Zhong, Jing
Wu, Xiaoai
Cheng, Yan
description Nuclear imaging of aggregated α-synuclein pathology is an urgent clinical need for Parkinson's disease, yet promising tracers for brain α-synuclein aggregates are still rare. In this work, a class of compact benzothiazole derivatives was synthesized and evaluated for α-synuclein aggregates. Among them, azobenzothiazoles exhibited specific and selective detection of α-synuclein aggregates under physiological conditions. Fluoro-pegylated azobenzothiazole NN-F further demonstrated high-affinity binding to α-synuclein aggregates and efficient 18F-radiolabeling via nucleophilic displacement of a tosyl precursor. [18F]NN-F was stable in plasma in vitro and showed efficient brain uptake with little defluorination in vivo.
doi_str_mv 10.1039/d4ob00492b
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_3057693051</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3064514154</sourcerecordid><originalsourceid>FETCH-LOGICAL-p146t-cfca2e6845271711285c046cbe63b1e22526d8327e51f214a1fc473347374d553</originalsourceid><addsrcrecordid>eNpdjs9KAzEQh4MoWKsXnyDgxctqJn93j1KtCgUverVks7PtljSpm6xg38oX8ZlcUDx4mJnvBx_Dj5BzYFfARHXdyFgzJiteH5AJSGMKpkR1-MecHZOTlDaMQWW0nJDXW3xHH3dbDJnGltpAoZwX3tbosaF2H2sM-5jX3Ygeae6tw562sadfn0X6CIPz2AVqV6seVzZjomPKa6R1b7twSo5a6xOe_d4peZnfPc8eisXT_ePsZlHsQOpcuNZZjrqUihswALxUjkntatSiBuRccd2UghtU0HKQFlonjRDjGNkoJabk8ufvro9vA6a83HbJofc2YBzSUjBldDVuGNWLf-omDn0Y242WlgokKCm-Ado7Yr0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3064514154</pqid></control><display><type>article</type><title>Development of an 18F-labeled azobenzothiazole tracer for α-synuclein aggregates in the brain</title><source>Royal Society of Chemistry</source><creator>Wu, Jiajun ; Mao, Meiting ; Yang, Jie ; Li, Kexin ; Deng, Pengxin ; Zhong, Jing ; Wu, Xiaoai ; Cheng, Yan</creator><creatorcontrib>Wu, Jiajun ; Mao, Meiting ; Yang, Jie ; Li, Kexin ; Deng, Pengxin ; Zhong, Jing ; Wu, Xiaoai ; Cheng, Yan</creatorcontrib><description>Nuclear imaging of aggregated α-synuclein pathology is an urgent clinical need for Parkinson's disease, yet promising tracers for brain α-synuclein aggregates are still rare. In this work, a class of compact benzothiazole derivatives was synthesized and evaluated for α-synuclein aggregates. Among them, azobenzothiazoles exhibited specific and selective detection of α-synuclein aggregates under physiological conditions. Fluoro-pegylated azobenzothiazole NN-F further demonstrated high-affinity binding to α-synuclein aggregates and efficient 18F-radiolabeling via nucleophilic displacement of a tosyl precursor. [18F]NN-F was stable in plasma in vitro and showed efficient brain uptake with little defluorination in vivo.</description><identifier>ISSN: 1477-0520</identifier><identifier>ISSN: 1477-0539</identifier><identifier>EISSN: 1477-0539</identifier><identifier>DOI: 10.1039/d4ob00492b</identifier><language>eng</language><publisher>Cambridge: Royal Society of Chemistry</publisher><subject>Aggregates ; Benzothiazole ; Brain ; Defluorination ; Movement disorders ; Neurodegenerative diseases ; Neuroimaging ; Parkinson's disease ; Radiolabelling ; Synuclein</subject><ispartof>Organic &amp; biomolecular chemistry, 2024-06, Vol.22 (22), p.4550-4558</ispartof><rights>Copyright Royal Society of Chemistry 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Wu, Jiajun</creatorcontrib><creatorcontrib>Mao, Meiting</creatorcontrib><creatorcontrib>Yang, Jie</creatorcontrib><creatorcontrib>Li, Kexin</creatorcontrib><creatorcontrib>Deng, Pengxin</creatorcontrib><creatorcontrib>Zhong, Jing</creatorcontrib><creatorcontrib>Wu, Xiaoai</creatorcontrib><creatorcontrib>Cheng, Yan</creatorcontrib><title>Development of an 18F-labeled azobenzothiazole tracer for α-synuclein aggregates in the brain</title><title>Organic &amp; biomolecular chemistry</title><description>Nuclear imaging of aggregated α-synuclein pathology is an urgent clinical need for Parkinson's disease, yet promising tracers for brain α-synuclein aggregates are still rare. In this work, a class of compact benzothiazole derivatives was synthesized and evaluated for α-synuclein aggregates. Among them, azobenzothiazoles exhibited specific and selective detection of α-synuclein aggregates under physiological conditions. Fluoro-pegylated azobenzothiazole NN-F further demonstrated high-affinity binding to α-synuclein aggregates and efficient 18F-radiolabeling via nucleophilic displacement of a tosyl precursor. [18F]NN-F was stable in plasma in vitro and showed efficient brain uptake with little defluorination in vivo.</description><subject>Aggregates</subject><subject>Benzothiazole</subject><subject>Brain</subject><subject>Defluorination</subject><subject>Movement disorders</subject><subject>Neurodegenerative diseases</subject><subject>Neuroimaging</subject><subject>Parkinson's disease</subject><subject>Radiolabelling</subject><subject>Synuclein</subject><issn>1477-0520</issn><issn>1477-0539</issn><issn>1477-0539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdjs9KAzEQh4MoWKsXnyDgxctqJn93j1KtCgUverVks7PtljSpm6xg38oX8ZlcUDx4mJnvBx_Dj5BzYFfARHXdyFgzJiteH5AJSGMKpkR1-MecHZOTlDaMQWW0nJDXW3xHH3dbDJnGltpAoZwX3tbosaF2H2sM-5jX3Ygeae6tw562sadfn0X6CIPz2AVqV6seVzZjomPKa6R1b7twSo5a6xOe_d4peZnfPc8eisXT_ePsZlHsQOpcuNZZjrqUihswALxUjkntatSiBuRccd2UghtU0HKQFlonjRDjGNkoJabk8ufvro9vA6a83HbJofc2YBzSUjBldDVuGNWLf-omDn0Y242WlgokKCm-Ado7Yr0</recordid><startdate>20240605</startdate><enddate>20240605</enddate><creator>Wu, Jiajun</creator><creator>Mao, Meiting</creator><creator>Yang, Jie</creator><creator>Li, Kexin</creator><creator>Deng, Pengxin</creator><creator>Zhong, Jing</creator><creator>Wu, Xiaoai</creator><creator>Cheng, Yan</creator><general>Royal Society of Chemistry</general><scope>7QO</scope><scope>7T7</scope><scope>7TM</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20240605</creationdate><title>Development of an 18F-labeled azobenzothiazole tracer for α-synuclein aggregates in the brain</title><author>Wu, Jiajun ; Mao, Meiting ; Yang, Jie ; Li, Kexin ; Deng, Pengxin ; Zhong, Jing ; Wu, Xiaoai ; Cheng, Yan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p146t-cfca2e6845271711285c046cbe63b1e22526d8327e51f214a1fc473347374d553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aggregates</topic><topic>Benzothiazole</topic><topic>Brain</topic><topic>Defluorination</topic><topic>Movement disorders</topic><topic>Neurodegenerative diseases</topic><topic>Neuroimaging</topic><topic>Parkinson's disease</topic><topic>Radiolabelling</topic><topic>Synuclein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Jiajun</creatorcontrib><creatorcontrib>Mao, Meiting</creatorcontrib><creatorcontrib>Yang, Jie</creatorcontrib><creatorcontrib>Li, Kexin</creatorcontrib><creatorcontrib>Deng, Pengxin</creatorcontrib><creatorcontrib>Zhong, Jing</creatorcontrib><creatorcontrib>Wu, Xiaoai</creatorcontrib><creatorcontrib>Cheng, Yan</creatorcontrib><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Organic &amp; biomolecular chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Jiajun</au><au>Mao, Meiting</au><au>Yang, Jie</au><au>Li, Kexin</au><au>Deng, Pengxin</au><au>Zhong, Jing</au><au>Wu, Xiaoai</au><au>Cheng, Yan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of an 18F-labeled azobenzothiazole tracer for α-synuclein aggregates in the brain</atitle><jtitle>Organic &amp; biomolecular chemistry</jtitle><date>2024-06-05</date><risdate>2024</risdate><volume>22</volume><issue>22</issue><spage>4550</spage><epage>4558</epage><pages>4550-4558</pages><issn>1477-0520</issn><issn>1477-0539</issn><eissn>1477-0539</eissn><abstract>Nuclear imaging of aggregated α-synuclein pathology is an urgent clinical need for Parkinson's disease, yet promising tracers for brain α-synuclein aggregates are still rare. In this work, a class of compact benzothiazole derivatives was synthesized and evaluated for α-synuclein aggregates. Among them, azobenzothiazoles exhibited specific and selective detection of α-synuclein aggregates under physiological conditions. Fluoro-pegylated azobenzothiazole NN-F further demonstrated high-affinity binding to α-synuclein aggregates and efficient 18F-radiolabeling via nucleophilic displacement of a tosyl precursor. [18F]NN-F was stable in plasma in vitro and showed efficient brain uptake with little defluorination in vivo.</abstract><cop>Cambridge</cop><pub>Royal Society of Chemistry</pub><doi>10.1039/d4ob00492b</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1477-0520
ispartof Organic & biomolecular chemistry, 2024-06, Vol.22 (22), p.4550-4558
issn 1477-0520
1477-0539
1477-0539
language eng
recordid cdi_proquest_miscellaneous_3057693051
source Royal Society of Chemistry
subjects Aggregates
Benzothiazole
Brain
Defluorination
Movement disorders
Neurodegenerative diseases
Neuroimaging
Parkinson's disease
Radiolabelling
Synuclein
title Development of an 18F-labeled azobenzothiazole tracer for α-synuclein aggregates in the brain
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A25%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20an%2018F-labeled%20azobenzothiazole%20tracer%20for%20%CE%B1-synuclein%20aggregates%20in%20the%20brain&rft.jtitle=Organic%20&%20biomolecular%20chemistry&rft.au=Wu,%20Jiajun&rft.date=2024-06-05&rft.volume=22&rft.issue=22&rft.spage=4550&rft.epage=4558&rft.pages=4550-4558&rft.issn=1477-0520&rft.eissn=1477-0539&rft_id=info:doi/10.1039/d4ob00492b&rft_dat=%3Cproquest%3E3064514154%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p146t-cfca2e6845271711285c046cbe63b1e22526d8327e51f214a1fc473347374d553%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3064514154&rft_id=info:pmid/&rfr_iscdi=true